Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Immunity|December 18, 2014
Balance and imbalance in the immune system: life on the edgeSuzanne L Topalian, Arlene H SharpeJournal for Immunotherapy of Cancer|January 24, 2025
Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of careSuzanne L Topalian, Drew M PardollHuman Gene Therapy|April 1, 2004
Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cellsGregory Lizée, Monica I Gonzales, Suzanne L TopalianScience (New York, N.Y.)|February 1, 2020
Neoadjuvant checkpoint blockade for cancer immunotherapySuzanne L Topalian, Janis M Taube, Drew M PardollCurrent Opinion in Immunology|January 13, 2012
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunitySuzanne L Topalian, Charles G Drake, Drew M PardollJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Cancer immunotherapy comes of ageSuzanne L Topalian, George J Weiner, Drew M PardollCancer Cell|April 11, 2015
Immune checkpoint blockade: a common denominator approach to cancer therapySuzanne L Topalian, Charles G Drake, Drew M PardollBiotechniques|January 27, 2004
Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCRJoeri L Aerts, Monica I Gonzales, Suzanne L TopalianMelanoma Research|May 15, 2008
Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomasSuhail K Mithani, Ian M Smith, Suzanne L Topalian, et al.Nature Reviews. Cancer|April 16, 2016
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapySuzanne L Topalian, Janis M Taube, Robert A Anders, et al.Pageof 11